| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg（以达比加群酯计） | 南京海辰药业股份有限公司 | Nanjing Hicin Pharmaceutical Co Ltd | 国药准字H20223738 | view | 2022-10-11 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg（以达比加群酯计） | 南京海辰药业股份有限公司 | Nanjing Hicin Pharmaceutical Co Ltd | 国药准字H20223739 | view | 2022-10-11 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg(以达比加群酯计) | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | 国药准字H20213235 | view | 2021-03-30 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg(以达比加群酯计) | 成都倍特药业股份有限公司 | Chengdu Brilliant Pharmaceutical Co Ltd | 国药准字H20213234 | view | 2021-03-30 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg(以达比加群酯计) | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 国药准字H20203098 | view | 2020-03-17 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg(以达比加群酯计) | 成都苑东生物制药股份有限公司,成都硕德药业有限公司 | Chengdu Easton Bio Pharmaceuticals Co Ltd | 国药准字H20213282 | view | 2021-04-13 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg(以达比加群酯计) | 成都苑东生物制药股份有限公司,成都硕德药业有限公司 | Chengdu Easton Bio Pharmaceuticals Co Ltd | 国药准字H20213281 | view | 2021-04-13 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 75mg（按C₃₄H₄₁N₇O₅计） | 齐鲁制药（海南）有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | 国药准字H20223325 | view | 2022-05-18 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg（按C₃₄H₄₁N₇O₅计） | 齐鲁制药（海南）有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | 国药准字H20223324 | view | 2022-05-18 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg（按C₃₄H₄₁N₇O₅计） | 齐鲁制药（海南）有限公司 | Qilu Pharmaceutical (Hainan) Co Ltd | 国药准字H20223323 | view | 2022-05-18 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg(以达比加群酯计) | 江苏豪森药业集团有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | 国药准字H20213088 | view | 2021-01-30 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg(以达比加群酯计) | 江苏豪森药业集团有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | 国药准字H20213087 | view | 2021-01-30 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 75mg(以达比加群酯计) | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 国药准字H20203097 | view | 2020-03-17 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg（以达比加群酯计） | 四川科伦药业股份有限公司 | Sichuan Kelun Pharmaceutical Co Ltd | 国药准字H20233016 | view | 2023-01-09 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 75mg（以达比加群酯计） | 四川科伦药业股份有限公司 | Sichuan Kelun Pharmaceutical Co Ltd | 国药准字H20233015 | view | 2023-01-09 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 110mg（以达比加群酯计） | 浙江华海药业股份有限公司 | Zhe Jiang Hua Hai Pharmaceutical Co Ltd | 国药准字H20233497 | view | 2023-04-28 | Medicare(class B) | view |
| 达比加群酯胶囊 | Dabigatran Etexilate | Capsule | 150mg（以达比加群酯计） | 浙江华海药业股份有限公司 | Zhe Jiang Hua Hai Pharmaceutical Co Ltd | 国药准字H20233496 | view | 2023-04-28 | Medicare(class B) | view |
